Cardima, Inc. is focused on the diagnosis and treatment of cardiac
arrhythmias. The Company's products have been developed for the
diagnosis and treatment of atrial fibrillation (AF) and ventricular
tachycardia (VT). It develops, manufactures and markets those products
for two distinct market segments: electrophysiology (EP) and cardiac
surgery. The Company's REVELATION family of micro-catheters can access
the atria of the heart in a minimally in...
more
Cardima, Inc. is focused on the diagnosis and treatment of cardiac
arrhythmias. The Company's products have been developed for the
diagnosis and treatment of atrial fibrillation (AF) and ventricular
tachycardia (VT). It develops, manufactures and markets those products
for two distinct market segments: electrophysiology (EP) and cardiac
surgery. The Company's REVELATION family of micro-catheters can access
the atria of the heart in a minimally invasive procedure. They are
designed to map and ablate the cardiac tissue creating long, thin,
continuous, linear lesions in the right or left atria and focal or
circumferential lesions in and around the pulmonary veins located in
the left atria. The PATHFINDER, PATHFINDER mini and TRACER diagnostic
micro-catheter systems for mapping VT are all designed for use inside
the vasculature of the heart wall, facilitating access to
arrhythmia-causing tissue through the venous system.
less
